GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lin BioScience Inc (ROCO:6696) » Definitions » Institutional Ownership

Lin BioScience (ROCO:6696) Institutional Ownership : 0.13% (As of Jun. 09, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Lin BioScience Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lin BioScience's institutional ownership is 0.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lin BioScience's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lin BioScience's Float Percentage Of Total Shares Outstanding is 0.00%.


Lin BioScience Institutional Ownership Historical Data

The historical data trend for Lin BioScience's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lin BioScience Institutional Ownership Chart

Lin BioScience Historical Data

The historical data trend for Lin BioScience can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.17 0.17 0.21 0.16 0.16 0.16 0.16 0.16 0.13 0.13

Lin BioScience Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Lin BioScience (ROCO:6696) Business Description

Traded in Other Exchanges
N/A
Address
Zhongxiao East Road, 12th Floor, No. 68, Section 5, Xinyi District, Taipei City, TWN, 110
Lin BioScience Inc is a drug development company. It specializes in therapies for diseases with unmet medical needs. Its novel pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in oncology, ophthalmology, cardiovascular, and metabolic disease.

Lin BioScience (ROCO:6696) Headlines

No Headlines